1.  

Article types	Original article
Language	English
Refereed paper	Refereed
Title	Prognostic impact of C-reactive protein and alpha-fetoprotein in immunotherapy score in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a multicenter retrospective study
Journal	Formal name：Hepatol Int. ISSN code：13866346
Domestic / Foregin	Foregin
Volume, Number, Page	16(5),pp.1150-1160
Papers・Author	Hatanaka Takeshi, Kakizaki Ssatoru, Hiraoka Atsushi, Tada Toshifumi, Hirooka Masashi, Kariyama Kazuya, Tani Joji, Atsukawa Masanori, Takaguchi Koichi, Itobayashi Ei, Fukunishi Shinya, Tsuji Kunihiko, Ishikawa Toru, Tajiri Kszuto, Ochi Hironori, Yasuda Satoshi, Toyoda Hidenori, Ogawa Chikara, Nishimura Takashi, Shimada Noritomo, Kawata Kazuhito, Kosaka Hisashi, Tanaka Takaaki, Ohama Hideko, Nouso Kazuhiro, Morishita Asahiro, Tsutsui Akemi, Nagano Takuya, Itokawa Norio, Okubo Tomomi, Arai Taeang, Imai Michitaka, Naganuma Atushi, Koizumi Yohei, Nakamura Shinichiro, Joko Kouji, Kaibori Masaki, Iijima Hiroko, Hiasa Yoichi, Kumada Takashi; Real-life Practice Experts for HCC (RELPEC) Study Group, and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan).
Publication date	2022